Back to search

Article

Assessing the availability of Repurposed Orphan Drugs in India

2022-12-26

Abstract excerpt

India has a massive burden of rare diseases (RDs), estimated to be around 96 million living patients but limited options for treatment. Drugs used for RDs are known as Orphan Drugs. Globally, 95% of RDs do not have an approved drug for treatment. Novel orphan drugs are characteristically expensive and out of reach for most Indian patients. Repurposing drugs used for other common conditions have been considered an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9785ae98-41b1-589e-94ef-bf21575b989b
DOI
10.1101/2022.12.22.22283870
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Assessing the availability of Repurposed Orphan Drugs in IndiaDOI 10.1101/2022.12.22.22283870
Select a neighboring publication to make it the new centre.